Introduction
Transcriptome studies have been done in multiple mouse DS models ( showed higher expression of neuronal transcripts when compared to disomic 117 iPSCs. To investigate differences between our analyses and previous studies, 118
we have compared global gene expression data among the related studies, and 119 find evidence for at least two different states for trisomic iPSC. We suggest that 120 these different states may reflect an inherent inability for trisomic iPSCs to 121 maintain full pluripotency. were passaged with dispase, and differentiating colonies were removed manually 134 by scraping. Periodically, live iPSC colonies were stained with anti-Tra-1-60 or 135
Tra-1-81 conjugated to Dylight fluor 488 to confirm the stem cell character of the 136 colonies. Likewise, fixed cells were shown to express Oct4 by immunostaining. 137
We used ABI/Thermo Fisher TaqMan Copy Number Assays (Hs01180853_cn; 138
Hs02928366_cn; Hs01533676 corresponding to APP, DYRK1A and RCAN1 139 respectively) to evaluate the number of copies of Chr. 21 in the iPSC lines. We 140 found that C2 was stably trisomic, but that C3 appeared initially to be a mixture of 141 trisomic and disomic cells that rapidly gave rise to a consistently disomic cell line, 142 which we call C3-D21. with Accutase, and plated on Geltrex-coated dishes at 10-20 x 10 3 cells/cm 2 in 149 mTeSR1 medium + 10 uM Y27632 ROCK inhibitor (Tocris). After 2-4 days, the 150 cells formed a meshwork of dense ridges with mostly open spaces in between. 151
The differentiation process was begun (day 0) by feeding the cells every other 152 day for 12 days with NIM neural induction medium (Stem Cell Technologies), 153 followed by DDM medium supplemented with 2% B27 (Gaspard et al., 2009 ) 154 every other day for 12 days. On day 24, the dense ridges or islands containing 155 neural progenitors were manually dissociated, resuspended in DDM + 2% B27 + 156 ornithine and laminin (Shi et al., 2012) . Every 4-5 days, half the medium was 158 changed to fresh Neurobasal + 2% B27 + 2mM GlutaMax (Invitrogen (Andrews, 2010) . Low quality bases 228 (q < 10) were trimmed from the 3' end of reads. Adaptor sequences and reads shorter than 40 nucleotides were removed using Trimmomatic (Bolger, 2014) . 230
Reads were aligned to GRCh37/hg19 using TopHat2 (v2.0.14, --b2-very-231 sensitive --keep---no-coverage-search --library-type fr-firststrand) (Kim et al., 232 2013 ). High quality mapped reads (MAPQ > 10) were filtered with SAMtools 233 (v0.1.19) (Li et al., 2009 ). Gene level counts were obtained using the GRCh37 234
Ensembl annotation with Rsubread (v 1.18.0, strandSpecific = 2, 235 GTF.featureType = "exon", countMultiMappingReads = FALSE) (Liao, 2013) . 236 Differential expression of genes was determined using DESeq (v1.24.0) software 237 with the options "per-condition", "maximum", and "local" for dispersion 238 calculations (Anders, 2010) . Significance was assigned to genes with an FDR 239 less than 10%. 240
241
Global RNA Editing 242 243
The bioinformatics scheme was implemented to specifically quantify the amount 244 of RNA editing that occurs in known RNA editing locations. With this is mind we 245 used the "DAtabase of RNa Editing" (DARNED) to procure a list of all previously 246 published RNA editing locations in the human genome (hg19) (Kiran, 2010) . Only 247 Adenosine to Inosine RNA editing sites in exons were used in the analysis. 248
Reads overlapping DARNED locations were kept if they were uniquely aligned 249 with a MAPQ greater than 10, and a minimum PHRED score of 30 at the 250 nucleotide level. An edit ratio was then determined for each location by summing 251 the total number of edits (A to G changes) divided by the total possible edits 252 (read depth at edit location). A minimum read depth of 10 was required for the edit ratio to be determined. The global editing percentage for each sample was 254 then ascertained by averaging all edit ratios considered. 255 256 Alternative splicing analysis 257 258 Splicing analysis was performed using Hartley's QoRTs / JunctionSeq pipeline 259 (Hartley, 2016) . Tophat aligned reads and an Ensembl annotation file (GRCh37) 260 were used as input to generate gene counts with QoRTs software using the 261 options "--stranded", "--singleEnded", and "--minMAPQ 50". A flat annotation file 262 containing known splice junctions was produced in QoRTs using the same 263 Ensembl annotation above with the "--stranded" option set. The QoRTs 264 generated files were both used as input into JunctionSeq for differential exon and Using a false discovery rate (FDR) of 10%, we identified 1644 transcripts (810 332 up, 834 down) with differential expression between trisomic and disomic iPSCs 333 (see Supplementary table 1) . Gene ontology analysis revealed that trisomic 334 iPSCs had increased transcript levels for genes involved in neurogenesis and 335 neuronal function (see Table 1 
344
To confirm the surprising observation that the trisomic iPSCs appeared to 345 express neuronal transcripts at higher levels than the paired disomic iPSCs, we 346 focused on MAP2, a classic neuronal-specific microtubule-binding protein whose 347 transcript was increased an average of 6 fold in the trisomic iPSCs compared to 348 the disomic iPSCs. As shown in Figure Supplementary Table 2 ). Gene ontology analysis of 363 differentially expressed transcripts (Table 1) identified similar functional 364 categories as observed in the precursor iPSCs. Transcripts for many GABA and 365 glutamate receptors were markedly increased in the trisomic neuronal cultures. 366
We note that transcripts for general neuronal markers (e.g., MAP2, βIII tubulin, 367 and SNAP25) were not increased in the trisomic neuronal cultures compared to 368 suggestions that excessive RNA editing may occur in trisomy 21 cells. To test 392 this hypothesis, we scored editing levels at ~10,000 residues annotated to 393 undergo A-to-I editing (the DARNED database) in the trisomic and disomic 394 neuronal cultures. (We did not score editing in the iPSCs, as A-to-I editing 395 happens preferentially in neuronal cells, and in fact the iPSCs had very low levels 396 of ADARB1 transcripts.) We found that ADARB1 transcripts are increased in the 397 trisomic neuronal cultures, however levels of these transcripts do not correlate 398 well with over all levels of A-to-I editing (see Figure 4 ). We conclude that 399 increased levels of ADARB1 transcripts do not lead to increases in global RNA 400 editing. Our dataset does not have sufficient read depth to determine rigorously 401 if there were significant changes in site-specific editing in the trisomic neuronal 402 cultures. 403 
. Correlation between ADARB1 transcript abundance and levels of global A-to-I editing.
Note that all trisomic cultures had higher normalized levels of ADARB1 transcripts, but this did not necessarily translate into higher editing rates. Comparison to other transcriptome data sets. 441
442
The iPSCs and induced neuronal cultures that we have characterized were 443 derived from a single individual, thereby intrinsically limiting the generalization of 444 our results. However, three datasets have been published that have attempted a 445 similar transcriptome characterization using trisomic/disomic iPSC pairs that 446 have the same genetic background within each study (Table 2) trisomy, and that enabled them to derive a trisomic/disomic iPSC pair. As we 454 have done, these studies all used statistical criteria to generate lists of genes 455 with differential expression in trisomic vs. disomic iPSCs. Comparison of these 456 lists identified no differentially expressed gene common to all the studies, except 457 for genes expressed on chromosome 21. There are multiple, non-mutually 458 exclusive, possible explanations for this observation: inherent variability in 459 independently-generated iPSCs, large effects of the experimental conditions 460 used in individual labs, insufficient replication to identify all transcriptome 461 differences accurately, strong effects of genetic background, one or more study 462 with outlying data, or a fundamental absence of a non-chromosome 21 transcriptome signature in trisomic iPSCs. To sort through these possibilities, we 464 undertook a cluster analysis to determine how the datasets grouped. In 465 particular, we sought to determine if our dataset was truly an outlier in 466 comparison to the previous studies. 467 468 
471
The relevant data from previous studies were downloaded from online 472 repositories, and trisomic/disomic ratios were calculated for all the annotated 473 genes assayed. This approach enabled us to use a dimensionless measure that 474 allowed comparison of RNA-seq and microarray data. Our study and the twin 475 study by Letourneau et al (2014) produced single sets of trisomic/disomic ratios. 476
The study by Weick et al (2013) generated two sets of ratios, using the data from 477 two trisomic clones (DS1 and DS4) and one disomic clone (DS2). (We 478 calculated the DS1/DS2 and DS4/DS2 ratios to maximize information, while 479 appreciating that these ratios are not independent because they use the same 480 denominator.) The study by Jiang et al (2013) examined 3 independent XIST 481 chromosome 21 insertion subclones derived from the same parental trisomic 482 iPSC clone. These subclones were subjected to doxycyline-induced XIST silencing, and trisomic/disomic ratios could be calculated by comparing 484 uninduced/induced transcriptome measurements, thus generating 3 independent 485 ratios (clones 1, 2, 3). The cluster analysis was based on the trisomic/disomic 486 ratios of our set of differentially expressed genes and the calculated ratios for the 487 same genes in the other datasets. After filtering for genes with values in at least 488 5/6 of the other datasets, 942 genes were used for the clustering analysis (see 489
Materials and Methods). 490 491 Figure 6A shows the dendrogram of the calculated dataset relationships. Note 492 that our dataset does not appear to be an outlier, but instead clusters with clone 493 3 of the study by Jiang et al (2013) and with the twin study of Letourneau et al. 494 (2014) . Figure 6B shows a portion of the gene expression heat map for the 495 clustered datasets, capturing genes that had increased expression (red color) in 496 our dataset (second column in heat map display). Note that these genes include fibroblasts and lymphoblast lines, likely due to increased expression in these 527 cells of the four interferon receptors (IFNAR1, IFNAR2, IFNGR2, and IL10RB) 528 located on chromosome 21. We find that these receptors also have increased 529 transcript accumulation in the trisomic iPSCs we analyzed, but this is not 530 apparent in the derived neuronal cultures. 531
532
As observed in other studies, the majority of significant transcriptome changes 533 we identified in both iPSCs and derived neuronal cultures occur in non-534 chromosome 21 genes. Gene ontology analysis of genes with transcript 535 abundance changes in trisomic iPSCs unexpectedly revealed increases in 536 transcripts from neuronal-associated genes and decreases in transcripts from 537 genes involved in cell adhesion function and germ layer/mesoderm development. 538
These differences did not result from visible spontaneous differentiation in the 539 trisomic iPSCs, which were monitored daily. We note, however, that cells in results is that the trisomic iPSC cultures contain higher proportions of stem cells 542 biased towards neuronal development. 543 544 One significant consideration in comparing the trisomic and disomic iPSCs used 545 in this study is that the disomic clones have gone through two cycles of selection: 546 first with G418 to select for the insertion of a dual selection cassette into exon 3 547 of the APP gene, and then with gancyclovir to select for loss of the chromosome 548 21 bearing the inserted selection cassette. It is possible that these rounds of 549 selection resulted in epigenetic (or, less likely, genetic) changes that added to the 550 transcriptional differences between the trisomic and disomic iPSCs. In fact, we 551 were unable to efficiently differentiate into cortical neuronal cultures any of the 4 552 disomic clones that had gone through these selection procedures. As the 553 differentiation protocol we used has been employed by other research groups to 554 produce cortical neuron cultures from iPSCs with normal karyotypes, we suspect 555 that the derivation of disomic clones may have resulted in a subtle intrinsic 556 change in the iPSC state. Fortunately, we were able to derive a spontaneous 557 disomic line from the C3 trisomic iPSC clone, which did readily differentiate into 558 cortical neurons. The C3 disomic iPSCs (C3-D21) were therefore used to 559 generate the disomic cortical neuronal cultures. Importantly, C3-D21 disomic 560 iPSCs expressed less MAP2 than trisomic iPSCs ( Figure 3C ), and we still 561 observed increased expression of neuronal-associated genes in the C2 trisomic 562 neuronal cultures compared to the disomic neuronal cultures derived from C3-563 D21. These observations argue that our finding that C2 trisomic cells have a more neuronal character than disomic cells from the same individual cannot be 565 attributed to an artifact of the genetically-selected disomic clones. 566
567
The neuronal differentiation protocol we used (Espuny-Camacho et al, 2013) 568 has been reported to result in the production of layer V and VI cortical neurons 569 after 40 days in culture, which we confirmed by immunofluorescence microscopy 570 using antibodies against layer V and VI -specific transcription factors CTIP2 and 571 TBR1, as well as antibodies to glutamate receptor GRIK2 and glutamate 572 transporter vGLUT1 ( Supplementary Figure 1) . While the neuronal cultures 573 derived from the trisomic and disomic iPSCs were not readily distinguishable 574 using any of these markers, there were significant transcriptome differences. Of 575 particular note was increased transcript accumulation for synaptic proteins, 576
including GABA (GABRG2, GABRA1, GABRB2, GABBR2) and glutamate 577 (GRIN2B, GRIA1) receptors in the trisomic iPSC-derived neuronal cultures. We 578 note that increased GABAnergic signaling occurs in the Ts65Dn mouse DS 579 model (Kleschevnikov et al, 2012a) , and counteracting GABAnergic inhibition in 580 these mice reverses behavioral deficits (Kleschevnikov et al, 2012b) . We did observe trisomy-dependent splicing changes in both the iPSCs and 606 neuronal cultures. Our identification of splicing alterations in trisomic cells is not 607 completely novel, as splicing differences in a selected set of genes has been 608 observed in fetal DS tissue (Toiber et al, 2010) . RNA-seq has also been used 609 previously to support altered splicing in DS endothelial progenitor cells, although 610 no confirmatory studies were done (Costa et al, 2011) . The large majority of 611 splicing changes we identified did not occur in genes located on chromosome 21, suggesting that they were not a direct effect of gene dosage (i.e., higher gene 613 dosage leading to competition for splicing factors and subsequent altered 614 splicing). More likely is the possibility that altered expression or altered activity of 615 splicing factors caused the splicing dysregulation observed in trisomic cells. We 616 did observe increased transcript accumulation for three known or The reduced HERVH expression we observe in trisomic iPSCs is consistent with these cells having an altered pluripotent state in comparison to the disomic 636 iPSCs. 637
638
Comparison with other datasets. 639 640 As described above, consideration of the possible effects of the selection 641 procedures used to generate the disomic derivative clones suggests a possible 642 technical reason why we have observed transcriptional differences not reported 643 by other investigators. However, cluster analysis of our dataset with other 644 comparable studies suggests that our results are not anomalous, but may reflect 645 the range of states assumed by human stem cells trisomic for chromosome 21. 646
The dendrogram shown in figure 6A could be interpreted as showing that there from the Jiang study, and both trisomic lines from the Wieck et al study). This is 651 likely an oversimplification; more extensive data might readily reveal a spectrum 652 of trisomic stem cell fates. However, this analysis does suggest that there is 653 unlikely to be a single transcriptome signature for trisomic stem cells, and the 654 observed transcriptome variation may not simply be a result of varying 655 experimental conditions. This latter point is supported by the observation that 656 clone 3 of the Jiang et al study clustered more closely with our data set than with 657 the other XIST clones. The Jiang study was particularly well controlled, as the 658 iPSCs were grown under the same conditions (using mouse embryonic fibroblasts as feeder cells) with the same length of XIST-based knockdown of 660 chromosome 21 expression (3 weeks). Nevertheless, clone 3 trisomic iPSCs 661 appeared more similar to ours, which were grown in feeder-free media. 662 663 Chromosome 21 trisomy and stem cell pluripotency. 664 665 Why might trisomic iPSCs show a range of transcriptome signatures? Given 666 our observation that the trisomic iPSCs we characterized had enhanced 667 accumulation of transcripts associated with differentiated neurons, and reduced 668 expression of the HERVH pluripotency marker, we speculate that trisomic iPSCs 669 may have an inherent inability to maintain a full pluripotent state. Following this 670 assumption, trisomic iPSCs would have a more constrained differentiation 671 capacity than corresponding disomic iPSCs, which could explain their reported 672 defects in neuronal differentiation (Jiang et al, 2013) . On the other hand, in the 673 absence of full pluripotency, trisomic iPSCs might alternatively be biased towards 674 ectodermal fates (e.g., the trisomic iPSCs we have characterized). The specific 675 developmental bias of a given trisomic iPSC might depend on a variety of factors: 676 genetic background, initial culture conditions, pluripotency factor expression, or 677 stochastic variation. If the gene dosage burden imposed by chromosome 21 678 trisomy generally interferes with the maintenance of stem cell fate, this might 679 account for some Down syndrome clinical phenotypes, including the 680 hematopoietic developmental defects observed in DS (Roberts and Izraeli, 681 2014). In this regard, it has been reported that the Ts65Dn mice have defects in 682 the self-renewal of hematopoietic stem cells as well as in the expansion of taken from the Letourneau study; the green trace is from the iPSCs used in this 804 study. Note that there are significantly different expression domains calculated 805 from the different studies (arrows). 806
